↑ 1.01.1Dwyer J, Li H, Xu D, Liu JP (Oct 2007). "Transcriptional regulation of telomerase activity: roles of the Ets transcription factor family". Annals of the New York Academy of Sciences. 1114 (1): 36–47. doi:10.1196/annals.1396.022. PMID17986575.
↑ 3.03.1Basuyaux JP, Ferreira E, Stéhelin D, Butticè G (Oct 1997). "The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner". The Journal of Biological Chemistry. 272 (42): 26188–95. doi:10.1074/jbc.272.42.26188. PMID9334186.
↑Kasten M, Giordano A (Apr 2001). "Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity". Oncogene. 20 (15): 1832–8. doi:10.1038/sj.onc.1204295. PMID11313931.
↑Wei G, Schaffner AE, Baker KM, Mansky KC, Ostrowski MC (2003). "Ets-2 interacts with co-repressor BS69 to repress target gene expression". Anticancer Research. 23 (3A): 2173–8. PMID12894593.
Further reading
Boulukos KE, Pognonec P, Sariban E, Bailly M, Lagrou C, Ghysdael J (Mar 1990). "Rapid and transient expression of Ets2 in mature macrophages following stimulation with cMGF, LPS, and PKC activators". Genes & Development. 4 (3): 401–9. doi:10.1101/gad.4.3.401. PMID2186967.
Watson DK, Mavrothalassitis GJ, Jorcyk CL, Smyth FE, Papas TS (Oct 1990). "Molecular organization and differential polyadenylation sites of the human ETS2 gene". Oncogene. 5 (10): 1521–7. PMID2250910.
Le Beau MM, Rowley JD, Sacchi N, Watson DK, Papas TS, Diaz MO (Nov 1986). "Hu-ets-2 is translocated to chromosome 8 in the t(8;21) in acute myelogenous leukemia". Cancer Genetics and Cytogenetics. 23 (3): 269–74. doi:10.1016/0165-4608(86)90189-5. PMID3021321.
Fujiwara S, Fisher RJ, Seth A, Bhat NK, Showalter SD, Zweig M, Papas TS (Feb 1988). "Characterization and localization of the products of the human homologs of the v-ets oncogene". Oncogene. 2 (2): 99–103. PMID3285299.
Sumarsono SH, Wilson TJ, Tymms MJ, Venter DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A, Kola I (Feb 1996). "Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice". Nature. 379 (6565): 534–7. doi:10.1038/379534a0. PMID8596630.
Basuyaux JP, Ferreira E, Stéhelin D, Butticè G (Oct 1997). "The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner". The Journal of Biological Chemistry. 272 (42): 26188–95. doi:10.1074/jbc.272.42.26188. PMID9334186.
Blumenthal SG, Aichele G, Wirth T, Czernilofsky AP, Nordheim A, Dittmer J (Apr 1999). "Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1". The Journal of Biological Chemistry. 274 (18): 12910–6. doi:10.1074/jbc.274.18.12910. PMID10212281.
Jayaraman G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Somasundaram K, Williams J, Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G, Thimmapaya B (Jun 1999). "p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter". The Journal of Biological Chemistry. 274 (24): 17342–52. doi:10.1074/jbc.274.24.17342. PMID10358095.
Kilpatrick LM, Kola I, Salamonsen LA (Jul 1999). "Transcription factors Ets1, Ets2, and Elf1 exhibit differential localization in human endometrium across the menstrual cycle and alternate isoforms in cultured endometrial cells". Biology of Reproduction. 61 (1): 120–6. doi:10.1095/biolreprod61.1.120. PMID10377039.
Rameil P, Lécine P, Ghysdael J, Gouilleux F, Kahn-Perlès B, Imbert J (Apr 2000). "IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells". Oncogene. 19 (17): 2086–97. doi:10.1038/sj.onc.1203542. PMID10815800.
Park US, Park SK, Lee YI, Park JG, Lee YI (Jul 2000). "Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells". Oncogene. 19 (30): 3384–94. doi:10.1038/sj.onc.1203674. PMID10918595.
Pastorcic M, Das HK (Nov 2000). "Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene". The Journal of Biological Chemistry. 275 (45): 34938–45. doi:10.1074/jbc.M005411200. PMID10942770.
Mullick J, Anandatheerthavarada HK, Amuthan G, Bhagwat SV, Biswas G, Camasamudram V, Bhat NK, Reddy SE, Rao V, Avadhani NG (May 2001). "Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter". The Journal of Biological Chemistry. 276 (21): 18007–17. doi:10.1074/jbc.M100671200. PMID11279115.
Kasten M, Giordano A (Apr 2001). "Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity". Oncogene. 20 (15): 1832–8. doi:10.1038/sj.onc.1204295. PMID11313931.